| Literature DB >> 31906433 |
Aurélie Hinsberger1, Benoît Graillot1, Christine Blachère Lopez1,2, Sylvie Juliant3, Martine Cerutti3, Linda A King4, Robert D Possee5, Franck Gallardo6,7, Miguel Lopez Ferber1.
Abstract
Many steps in the baculovirus life cycle, from initial ingestion to the subsequent infection of all larval cells, remain largely unknown; primarily because it has hitherto not been possible to follow individual genomes and their lineages. Use of ANCHORTM technology allows a high intensity fluorescent labelling of DNA. When applied to a virus genome, it is possible to follow individual particles, and the overall course of infection. This technology has been adapted to enable labelling of the baculovirus Autographa californica Multiple NucleoPolyhedroVirus genome, as a first step to its application to other baculoviruses. AcMNPV was modified by inserting the two components of ANCHORTM: a specific DNA-binding protein fused to a fluorescent reporter, and the corresponding DNA recognition sequence. The resulting modified virus was stable, infectious, and replicated correctly in Spodoptera frugiperda 9 (Sf9) cells and in vivo. Both budded viruses and occlusion bodies were clearly distinguishable, and infecting cells or larvae allowed the infection process to be monitored in living cells or tissues. The level of fluorescence in the culture medium of infected cells in vitro showed a good correlation with the number of infectious budded viruses. A cassette that can be used in other baculoviruses has been designed. Altogether our results introduce for the first time the generation of autofluorescent baculovirus and their application to follow infection dynamics directly in living cells or tissues.Entities:
Keywords: baculovirus infection; fluorescence labelling; real-time imaging
Year: 2020 PMID: 31906433 PMCID: PMC7019957 DOI: 10.3390/v12010050
Source DB: PubMed Journal: Viruses ISSN: 1999-4915 Impact factor: 5.048
Figure 1(a) Construction and function of the AcMNPV1–ANCHOR3 virus containing both ANCH3 and OR3-GFP. (b) Schematic to show function of a ANCHOR3™ virus. (1) OR3-GFP expression; (2) OR3-GFP binding to ANCH3 sequence (up to 500 particles per ANCH3 site); (3) Excitation of viral DNA containing ANCHOR3™ cassette at 485 nm; (4) Light emission at 535 nm.
Figure 2AcMNPV2–ANCHOR3 construction. Both components of the ANCHOR3™ system were inserted into a single transfer vector based on pAcUW2B, where the p10 promoter region was substituted by the A3-OR3-GFP-STA3. The OR3-GFP sequences were inserted between the polh gene and the A3 promoter, at the EcoRV site.
Figure 3Visualization of recombinant virus infection by fluorescence microscopy using a Zeiss Axiovert Observer Z1 in (a) S. frugiperda living cells at 18 hp.i. Arrow shows individual OBs (Sf9), (b) Alive S. exigua larva at 48 hp.i. Arrow shows tracheal epitheium infectedand (c) cross-section reconstruction of larva showing midgut infection at 48 h.pi.
Figure 4One step growth curve of Wildtype (Wt) and recombinant AcMNPV1–ANCHOR3 virus. The titers correspond to the average of three independent titrations.
Titers obtained by plaque assay of different passages (Ai) for AcMNPV–Wt and AcMNPV1–ANCHOR.
| Virus | A3 | A4 | A5 | Mean | SD |
|---|---|---|---|---|---|
| AcMNPV–Wt | 5.80 × 107 | 9.10 × 106 | 1.93 × 107 | 2.88 × 107 | 2.58 × 107 |
| AcMNPV1–ANCHOR3 | 2.42 × 107 | 3.12 × 106 | 1.27 × 107 | 1.33 × 107 | 1.06 × 107 |
Figure 5Events of Sf9 cell infection by AcMNPV1–ANCHOR3 visualized with a Zeiss Axiovert Observer Z1 (×63 objective) (a) Nucleocapsids (arrow) migrating from the nucleus to the cytoplasmic membrane to release BV; (b) BVs (arrow) releasing from infected cell; (c) New progeny viruses (arrow) labelled with ANCHOR3TM in the culture medium; (d) OBs (arrow) accumulation in the nucleus of the infected cell. Scale bar = 10 µm.
Figure 6Sf9 cells infection by AcMNPV–ANCHOR visualized with Zeiss Axiovert Observer Z1 (×63 objective) (a) early in infection, 6 hp.i. to 8 hp.i; (b) late in infection: 28 hp.i. to 32 hp.i. Scale bar = 10 µm.
Figure 7Use of fluorimetry to analyze BV dynamics. (a) Fluorimetric quantification of recombinant BV production. (b) Correlation between flurometric counts and plaque assay estimation of BV number.